Published in Proc Soc Exp Biol Med on July 01, 1970
Immune Profile of Patients With Sepsis (IPSEPSIS) | NCT04163705
Levels of lysosomal enzymes in tissues of mice infected with Mycoplasma fermentans. Infect Immun (1975) 0.76
Impact of encephalopathy on mortality in the sepsis syndrome. The Veterans Administration Systemic Sepsis Cooperative Study Group. Crit Care Med (1990) 2.04
Tissue factor pathway inhibitor reduces mortality from Escherichia coli septic shock. J Clin Invest (1993) 2.00
The pattern of lung disease associated with alpha antitrypsin deficiency. Arch Intern Med (1968) 1.35
Effects of acetylsalicylic acid on the canine response to endotoxin. J Pharmacol Exp Ther (1967) 1.33
Diaphragm function after upper abdominal surgery in humans. Am Rev Respir Dis (1983) 1.31
Antitrypsin deficiency in pulmonary disease: the significance of intermediate levels. Ann Intern Med (1969) 1.24
Cardiorespiratory and metabolic responses to liver E. coli and endotoxin in the monkey. J Appl Physiol (1969) 1.16
Effects of endotoxin on pulmonary capillary permeability, ultrastructure, and surfactant. Surg Gynecol Obstet (1969) 1.14
Mesenteric vascular responses to endotoxin in the monkey and dog. Am J Physiol (1970) 1.12
The pulmonary ultrastructure in septic shock. Exp Mol Pathol (1970) 1.12
Effect of indomethacin in endotoxin shock in the dog. Proc Soc Exp Biol Med (1967) 1.09
A model for thrombin protection against endotoxin. Thromb Res (1984) 1.09
Effectiveness of steroid/antibiotic treatment in primates administered LD100 Escherichia coli. Ann Surg (1981) 1.08
Survival of primates in LD100 septic shock following steroid/antibiotic therapy. J Surg Res (1980) 1.07
Continuous arteriovenous hemofiltration therapy for Staphylococcus aureus-induced septicemia in immature swine. Crit Care Med (1993) 1.05
Detection of the 'hyperdynamic state' of sepsis in the baboon during lethal E. coli infusion. J Trauma (1983) 1.04
Response of the subhuman primate in gram-negative septicemia induced by live Escherichia coli. Surg Gynecol Obstet (1971) 1.04
Comparison of canine responses to Escherichia coli organisms and endotoxin. Surg Gynecol Obstet (1968) 1.04
Effects of ouabain on splanchnic hemodynamics in the rhesus monkey. Am Heart J (1971) 1.03
Prevention of death in endotoxin shock by glucose administration. Surg Gynecol Obstet (1974) 1.01
Responses of the baboon to live Escherichia coli organisms and endotoxin. Surg Gynecol Obstet (1977) 1.01
Effects of endotoxin on myocardial hemodynamics, performance, and metabolism. Am J Physiol (1971) 1.01
On the delivery of intensive care. Can Med Assoc J (1975) 1.00
Effects of endotoxin on myocardial hemodynamics, performance, and metabolism during beta adrenergic blockade. Proc Soc Exp Biol Med (1971) 1.00
Cardiovascular responses of the primate in endotoxin shock. Am J Physiol (1966) 1.00
Plasma endotoxin concentration in healthy primates and during E. coli-induced shock. Crit Care Med (1988) 0.99
Recombinant E. coli-derived tissue factor pathway inhibitor reduces coagulopathic and lethal effects in the baboon gram-negative model of septic shock. Circ Shock (1994) 0.99
Effect of acetylsalicylic acid on the liver response to endotoxin. Proc Soc Exp Biol Med (1968) 0.99
Effectiveness of modified steroid-antibiotic therapies for lethal sepsis in the dog. Arch Surg (1983) 0.98
A pathologic study of Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment. Surg Gynecol Obstet (1978) 0.98
Prolonged shock in the baboon subjected to infusion of E. coli endotoxin. Circ Shock (1978) 0.97
The pattern of inheritance of alpha 1 antitrypsin deficiency and associated pulmonary disease. Am Rev Respir Dis (1969) 0.96
Acute supine respiratory failure due to bilateral diaphragmatic paralysis. Chest (1977) 0.96
Acute changes in oxyhemoglobin affinity. Effects on oxygen transport and utilization. J Clin Invest (1973) 0.96
Recovery from lethal Escherichia coli shock in dogs. Surg Gynecol Obstet (1979) 0.96
Mechanisms of impaired cardiac function by vasopressin. Ann Surg (1980) 0.95
Blood affinity for oxygen in hemorrhagic and endotoxic shock. J Appl Physiol (1972) 0.95
Immediate hemodynamic response of patients with atrioventricular block and cardiac failure to transvenous pacing. Circulation (1969) 0.93
Comparison of the capacity of rhTNF-alpha and Escherichia coli to induce procoagulant activity by baboon mononuclear cells in vivo and in vitro. Shock (1996) 0.93
Elevated plasma vasopressin concentrations during endotoxin and E. coli shock. Adv Shock Res (1981) 0.92
Pulmonary intravascular leukocyte sequestration. A potential mechanism of lung injury. Am Rev Respir Dis (1974) 0.90
Hemodynamic and respiratory responses of conscious swine to Escherichia coli endotoxin. Surg Forum (1973) 0.89
Corticosteroid/antibiotic treatment of adrenalectomized dogs challenged with lethal E. coli. Circ Shock (1985) 0.89
Mechanism of decreased venous return. Subhuman primate-administered endotoxin. Arch Surg (1970) 0.89
Attenuation of tissue thrombosis and hemorrhage by ala-TFPI does not account for its protection against E. coli--a comparative study of treated and untreated non-surviving baboons challenged with LD100 E. coli. Thromb Haemost (1998) 0.88
Baboon model of Escherichia coli sepsis: description of its four stages and the role of tumor necrosis factor, tissue factors, and the protein C system in septic shock. Curr Stud Hematol Blood Transfus (1991) 0.88
Familial alpha-1, antitrypsin deficiency and pulmonary emphysema. Trans Am Clin Climatol Assoc (1969) 0.88
Alpha 1 antitrypsin deficiency and pulmonary emphysema. Annu Rev Med (1971) 0.88
Pulmonary effects of E. coli endotoxin: role of leukocytes and platelets. Ann Surg (1972) 0.88
Role of the heart in the pathogenesis of endotoxin shock. A review of the clinical findings and observations on animal species. J Surg Res (1974) 0.88
Effects of steroid pretreatment on development of shock lung. Hemodynamic, respiratory, and morphologic studies. Lab Invest (1972) 0.87
Precipitation of cardiac failure in endotoxin shock. Surg Gynecol Obstet (1972) 0.87
Significance of leukocytes in endotoxic shock. Exp Mol Pathol (1975) 0.87
Preclinical review of anti-tumor necrosis factor monoclonal antibodies. Crit Care Med (1993) 0.87
Erythrocyte deformability in canine septic shock and the efficacy of pentoxifylline and a leukotriene antagonist. Proc Soc Exp Biol Med (1987) 0.86
Endotoxin shock. Hemodynamic and survival effects of methylprednisolone. Arch Surg (1967) 0.86
Pathophysiologic responses of the subhuman primate in experimental septic shock. Lab Invest (1975) 0.86
Current management of the septic shock patient: experimental basis for treatment. Circ Shock (1982) 0.85
Pathophysiology of the pulmonary circulation in emphysema associated with alpha antitrypsin deficiency. Circulation (1971) 0.85
Escherichia coli shock in the baboon and the response to adrenocorticosteroid treatment. Surg Gynecol Obstet (1978) 0.85
Myocardial function in shock. Am J Physiol (1974) 0.85
Renal gluconeogenesis and increased glucose utilization in shock. Am J Physiol (1976) 0.84
Reversal of myocardial dysfunction in endotoxin shock with insulin. Can J Physiol Pharmacol (1978) 0.84
Response of isolated liver to endotoxin. Can J Physiol Pharmacol (1966) 0.84
Toward prevention of postoperative pulmonary complications. Am Rev Respir Dis (1984) 0.83
Renal hemodynamics and function in response to renal artery occlusion in canine and primate kidneys. Invest Urol (1970) 0.83
The role of diaphragm function in disease. Arch Intern Med (1979) 0.83
Effect of endotoxin on isogravimetric capillary pressure in the forelimb. Am J Physiol (1968) 0.83
Increased survival with methylprednisolone treatment in canine endotoxin shock. J Surg Res (1978) 0.83
Sequential renal alterations in septic shock in the primate. Circ Shock (1991) 0.83
Protein C, isolation and potential use in prevention of thrombosis. Dev Biol Stand (1987) 0.82
Effects of E. coli septic shock on pulmonary hemodynamics and capillary permeability. J Thorac Cardiovasc Surg (1971) 0.82
Myocardial function in endotoxin shock. Circ Shock Suppl (1979) 0.82
Peritonitis in the baboon: a primate model which stimulates human sepsis. Shock (2000) 0.81
The removal of 14C labeled endotoxin by activated charcoal. Int J Artif Organs (1979) 0.81
Prevention and reversal of myocardial failure in endotoxin shock. Surg Gynecol Obstet (1973) 0.81
Cardiac response to circulating factors in endotoxin shock. Am J Physiol (1972) 0.81
Fat embolism syndrome. Changing prognosis. Chest (1981) 0.81
The mechanism of histamine-induced transcapillary fluid movement. Pflugers Arch (1969) 0.80
Cardiopulmonary effects of volume loading of primates in endotoxin shock. Surgery (1974) 0.80
Emphysema associated with intravascular leukocyte sequestration. Comparison with papain-induced emphysema. Am Rev Respir Dis (1981) 0.80
Effects of coronary hypotension and endotoxin on myocardial performance. Am J Physiol (1974) 0.80
Physiologic effects of passive hyperventilation on oxygen delivery and consumption. 1. Proc Soc Exp Biol Med (1972) 0.80
Effect of the South Polar Plateau on plasma and urine erythropoietin levels. Arch Intern Med (1970) 0.80
Leukocyte response and hypoglycemia in superlethal endotoxic shock. Circ Shock (1977) 0.80
Short-term changes in sleep patterns on arrival at the South Polar Plateau. Arch Intern Med (1970) 0.79
Lupus humoral autoimmunity induced in a primate model by short peptide immunization. J Investig Med (1998) 0.79
Effects of prior administration of steroids upon recovery from lethal sepsis. Surg Gynecol Obstet (1986) 0.79
Release of leukemia inhibitory factor in primate sepsis. Analysis of the role of TNF-alpha. J Immunol (1996) 0.79
Glucose utilization and role of blood in endotoxin shock. Am J Physiol (1977) 0.79